Back to search

Article

Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis

2023-01-22

Abstract excerpt

<h4>ABSTRACT</h4> Ulcerative colitis (UC) is driven by immune and stromal subsets, culminating in epithelial injury. Vedolizumab (VDZ) is an anti-integrin antibody that is effective for treating UC. VDZ is known to inhibit lymphocyte trafficking to the intestine, but its broader effects on other cell subsets are less defined. To identify the inflammatory cells that contribute to colitis and are affected by VDZ, w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
80bbd420-d511-5fef-8940-798987c70de8
DOI
10.1101/2023.01.21.525036
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitisDOI 10.1101/2023.01.21.525036
Select a neighboring publication to make it the new centre.